Related references
Note: Only part of the references are listed.Mucormycosis with orbital compartment syndrome in a patient with COVID-19
Amanda Werthman-Ehrenreich
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)
Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group
S. Rocchi et al.
MEDICAL MYCOLOGY (2021)
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Andre K. Johnson et al.
MEDICAL MYCOLOGY CASE REPORTS (2021)
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
Daniela Pasero et al.
INFECTION (2021)
Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome
Zesemayat K. Mekonnen et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2021)
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
Sameh S. M. Soliman et al.
NATURE MICROBIOLOGY (2021)
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2021)
EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group
Matteo Bassetti et al.
CLINICAL INFECTIOUS DISEASES (2021)
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
Martin Hoenigl et al.
LANCET INFECTIOUS DISEASES (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19)
Mahboobeh Karimi-Galougahi et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)
A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19
Anubhav Kanwar et al.
JOURNAL OF FUNGI (2021)
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
Christoph Zurl et al.
JOURNAL OF FUNGI (2021)
The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection
Anthony J. Carlos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis
Teclegiorgis Gebremariam et al.
JOURNAL OF FUNGI (2021)
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Teny M. John et al.
JOURNAL OF FUNGI (2021)
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
Juergen Prattes et al.
INTENSIVE CARE MEDICINE (2021)
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature
Akshay Khatri et al.
JOURNAL DE MYCOLOGIE MEDICALE (2021)
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries
Shivaprakash M. Rudramurthy et al.
MYCOSES (2021)
COVID-19-Associated Mold Infection in Critically Ill Patients, Chile
Ricardo Rabagliati et al.
EMERGING INFECTIOUS DISEASES (2021)
COVID-19 and orbital mucormycosis
Sandip Sarkar et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2021)
SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis
Aditya Moorthy et al.
JOURNAL OF MAXILLOFACIAL & ORAL SURGERY (2021)
Host-Pathogen Molecular Factors Contribute to the Pathogenesis of Rhizopus spp. in Diabetes Mellitus
Berenice Morales-Franco et al.
CURRENT TROPICAL MEDICINE REPORTS (2021)
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
Deepak Garg et al.
MYCOPATHOLOGIA (2021)
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Janis A. Mueller et al.
NATURE METABOLISM (2021)
Mucor in a Viral Land: A Tale of Two Pathogens
Mrittika Sen et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2021)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
A. Patel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey
Ban Hock Tan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Mucormycosis
Gail Reid et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis
Helene Guegan et al.
JOURNAL OF INFECTION (2020)
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
Abdullah Alqarihi et al.
MBIO (2020)
No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science
Monica Salerno et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19
C. Poignon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment
Amir Arastehfar et al.
JOURNAL OF FUNGI (2020)
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
Amir Arastehfar et al.
JOURNAL OF FUNGI (2020)
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Philipp Koehler et al.
LANCET INFECTIOUS DISEASES (2020)
Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in COVID-19 Patient: A Case Report
Epifanio Silvino do Monte Junior et al.
CLINICAL ENDOSCOPY (2020)
Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities
Michael D. Schwartz et al.
AGING AND DISEASE (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study
Brian Hanley et al.
LANCET MICROBE (2020)
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2019)
Global Epidemiology of Mucormycosis
Hariprasath Prakash et al.
JOURNAL OF FUNGI (2019)
Serial Detection of Circulating Mucorales DNA in Invasive Mucormycosis: A Retrospective Multicenter Evaluation
Toine Mercier et al.
JOURNAL OF FUNGI (2019)
Molecular Strategies to Diagnose Mucormycosis
Laurence Millon et al.
JOURNAL OF FUNGI (2019)
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
John R. Perfect et al.
MYCOSES (2018)
Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy
Jeffrey D. Jenks et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins
Sebastian Wurster et al.
VIRULENCE (2017)
RNAi-Based Functional Genomics Identifies New Virulence Determinants in Mucormycosis
Trung Anh Trieu et al.
PLOS PATHOGENS (2017)
Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates
Jesus Guinea et al.
PLOS ONE (2017)
Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients
Leonardo Potenza et al.
BLOOD (2011)
The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts
Sarah P. Georgiadou et al.
CLINICAL INFECTIOUS DISEASES (2011)
In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes
Eric Dannaoui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
AMBIZYGO:: phase II study of high dose liposomal amphotericin B (AmBisome®) [10 mg/kg/j] efficacy against zygomycosis
F. Lanternier et al.
MEDECINE ET MALADIES INFECTIEUSES (2008)
Epidemiology and outcome of zygomycosis: A review of 929 reported cases
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2005)
Unusual fungal pathogens in fungal rhinosinusitis
WA Schell
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2000)